Efficacy of nirsevimab against respiratory syncytial virus lower respiratory tract infections in preterm and term infants, and pharmacokinetic extrapolation to infants with congenital heart disease and chronic lung disease: a pooled analysis of randomised controlled trials

  1. Simões, E.A.F.
  2. Madhi, S.A.
  3. Muller, W.J.
  4. Atanasova, V.
  5. Bosheva, M.
  6. Cabañas, F.
  7. Baca Cots, M.
  8. Domachowske, J.B.
  9. Garcia-Garcia, M.L.
  10. Grantina, I.
  11. Nguyen, K.A.
  12. Zar, H.J.
  13. Berglind, A.
  14. Cummings, C.
  15. Griffin, M.P.
  16. Takas, T.
  17. Yuan, Y.
  18. Wählby Hamrén, U.
  19. Leach, A.
  20. Villafana, T.
Aldizkaria:
The Lancet Child and Adolescent Health

ISSN: 2352-4642

Argitalpen urtea: 2023

Alea: 7

Zenbakia: 3

Orrialdeak: 180-189

Mota: Artikulua

DOI: 10.1016/S2352-4642(22)00321-2 GOOGLE SCHOLAR